tiprankstipranks
Purple Biotech (PPBT)
NASDAQ:PPBT
Holding PPBT?
Track your performance easily

Purple Biotech (PPBT) Income Statement

938 Followers

Purple Biotech Income Statement

Last quarter (Q4 2023), Purple Biotech's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Purple Biotech's net income was $―. See Purple Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
--$ 92.00K$ 18.38M$ 29.00M$ 1.00M
Cost of Revenue
---$ 212.00K--
Gross Profit
--$ 92.00K$ -212.00K$ 29.00M$ 2.51M
Operating Expense
$ 8.67M$ 22.27M$ 22.67M$ 17.93M$ 13.30M$ 8.75M
Operating Income
$ -8.67M$ -22.27M$ -22.58M$ -18.15M$ -13.30M$ -6.24M
Net Non Operating Interest Income Expense
$ 270.00K$ -1.19M$ 916.00K$ 320.00K$ 28.25M$ 151.00K
Other Income Expense
-$ -3.50M-$ -18.47M$ -28.07M$ -5.85M
Pretax Income
$ -8.40M$ -19.98M$ 21.68M$ 19.03M$ -702.00K$ -423.00K
Tax Provision
--$ -21.76M$ -17.83M-$ 216.00K
Earnings From Equity Interest Net Of Tax
----$ 28.07M-
Net Income Common Stockholders
$ -8.36M$ -19.88M$ 43.53M$ 37.58M$ 43.55M$ -596.00K
Basic EPS
-$ 0.90--$ 2.44$ 3.00
Diluted EPS
-$ 0.90-$ 0.04$ 2.44-
Basic Average Shares
-$ 22.13M-$ 17.57M$ 17.85M$ 1.94M
Diluted Average Shares
-$ 22.13M-$ 17.57M$ 17.85M$ 1.77M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 8.67M$ 22.27M$ 22.67M$ 18.15M$ 13.30M$ 8.75M
Net Income From Continuing And Discontinued Operation
$ -8.36M$ -19.88M$ 43.53M$ 37.58M$ 43.55M$ -596.00K
Normalized Income
$ -8.36M-----
Interest Expense
$ 67.00K-----
EBIT
$ -8.33M-$ 21.68M$ 19.03M$ -702.00K$ -423.00K
EBITDA
$ -8.23M-$ 21.88M$ -17.59M$ -467.00K$ -245.00K
Currency in USD

Purple Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis